Optiver Holding
URGN icon

Optiver Holding’s UroGen Pharma URGN Stock Holding History

Optiver Holding’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65K Sell
72
-80
-53% -$2.17K ﹤0.01% 2224
2026
Q1 		$2.73K Sell
152
-71
-32% -$1.42K ﹤0.01% 1710
2025
Q4 		$5.22K Sell
223
-59
-21% -$1.28K ﹤0.01% 1334
2025
Q3 		$5.63K Buy
+282
New +$5.06K ﹤0.01% 1644

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Optiver Holding's URGN Position: Q2 2026 in Review

Optiver Holding reduced its UroGen Pharma (URGN) stake by 53% in Q2 2026, selling an estimated $2.17K and leaving 72 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2224.

Optiver Holding first reported a position in URGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.63K in Q3 2025. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Optiver Holding held 72 shares of UroGen Pharma worth $2.65K as of Q2 2026.
  • Optiver Holding sold 80 UroGen Pharma shares in Q2 2026, an estimated $2.17K.
  • UroGen Pharma made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2224 holding.
  • Optiver Holding first reported a position in UroGen Pharma in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's UroGen Pharma position peaked at $5.63K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.